NASDAQ:CME

CME Group - CME Price Target & Analyst Ratings

$202.11

+1.77 (+0.88%)

(As of 09/8/2022 11:11 AM ET)

Add

Compare

Today's Range: $198.69
▼
$202.17
50-Day Range: $194.69
▼
$208.90
52-Week Range: $185.79
▼
$256.94

Volume: 8,159 shs
Average Volume: 1.34 million shs
Market Capitalization: $72.65 billion

P/E Ratio: 25.08
Dividend Yield: 2.02%
Price Target: $230.80

CME Group Consensus Rating and Price Target (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 16 Analyst Ratings

Consensus Analyst Price Target

$230.80
14.20% Upside

High Prediction	$280.00
Average Prediction	$230.80
Low Prediction	$171.00

Type	Current 9/8/21 to 9/8/22	1 Month Ago 8/9/21 to 8/9/22	3 Months Ago 6/10/21 to 6/10/22	1 Year Ago 9/8/20 to 9/8/21
Consensus Rating	Hold	Hold	Hold	Hold
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	6 Buy rating(s)	7 Buy rating(s)	7 Buy rating(s)	4 Buy rating(s)
Hold	8 Hold rating(s)	8 Hold rating(s)	8 Hold rating(s)	8 Hold rating(s)
Sell	2 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	2 Sell rating(s)
Consensus Price Target	$230.80	$237.67	$246.73	$200.83
Predicted Upside	14.20% Upside	11.81% Upside	11.03% Upside	3.40% Upside

Get CME Group Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CME and its competitors with MarketBeat's FREE daily newsletter.

CME Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CME Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

CME Group Stock vs. The Competition

Type	CME Group	Finance Companies	S&P 500
Consensus Rating Score	2.25	2.50	2.49
Consensus Rating	Hold	Hold	Hold
Predicted Upside	15.20% Upside	66.56% Upside	21.73% Upside
News Sentiment Rating	Neutral News	Neutral News	Neutral News
MarketBeat Community Rating	Outperform Votes 645 62.32% Underperform Votes 390 37.68%	Avg. Outperform Votes 150 62.50% Avg. Underperform Votes 90 37.50%	Avg. Outperform Votes 851 68.46% Avg. Underperform Votes 392 31.54%

Historical Target Prices and Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
9/6/2022	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral	$216.00 ➝ $210.00	+7.86%
8/16/2022	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Sell	$171.00	-16.77%
8/15/2022	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform
8/12/2022	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold	$208.00 ➝ $212.00	+6.07%
8/2/2022	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy	$246.00 ➝ $240.00	+22.82%
7/28/2022	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Equal Weight	$242.00 ➝ $226.00	+15.36%
6/10/2022	Atlantic Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Simon Clinch Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Overweight	$235.00	+18.73%
5/31/2022	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Daniel Fannon Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$267.00	+34.04%
5/25/2022	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Market Perform ➝ Outperform	$223.00	+16.35%
5/16/2022	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$230.00	+14.94%
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
4/28/2022	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$275.00 ➝ $280.00	+23.93%
2/10/2022	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral	$202.00 ➝ $201.00	-17.62%
2/10/2022	Compass Point Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral	$235.00 ➝ $250.00	+2.46%
2/10/2022	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Underperform	$244.00 ➝ $252.00	+3.28%
10/1/2021	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Richard Repetto Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy	$230.00	+18.41%
9/15/2021	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Hold
3/1/2021	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Underperform ➝ Market Perform	$181.00 ➝ $197.00	-1.35%
2/25/2021	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Equal Weight ➝ Overweight	$230.00	+14.60%
1/12/2021	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight	$200.00 ➝ $215.00	+8.07%
9/11/2020	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Sell	$138.00	-15.82%
6/22/2020	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral	$175.00 ➝ $170.00	-3.14%
4/29/2020	Cfra Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Hold	$218.00 ➝ $205.00	+11.60%
1/10/2020	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform

(Data available from 9/8/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)

CME Price Target - Frequently Asked Questions

What is CME Group's consensus rating and price target?: According to the issued ratings of 16 analysts in the last year, the consensus rating for CME Group stock is Hold based on the current 2 sell ratings, 8 hold ratings and 6 buy ratings for CME. The average twelve-month price prediction for CME Group is $230.80 with a high price target of $280.00 and a low price target of $171.00. Learn more on CME's analyst rating history.
Do Wall Street analysts like CME Group more than its competitors?: Analysts like CME Group less than other Finance companies. The consensus rating score for CME Group is 2.25 while the average consensus rating score for finance companies is 2.50. Learn more on how CME compares to other companies.
Do MarketBeat users like CME Group more than its competitors?: MarketBeat users like CME Group less than other Finance companies. 62.32% of MarketBeat users gave CME Group an outperform vote while finance companies recieve an average of 62.50% outperform votes by MarketBeat users.

Is CME Group being upgraded or downgraded by Wall Street analysts?: Over the previous 90 days, CME Group's stock had 1 upgrade and 1 downgrade by analysts.
Does CME Group's stock price have much upside?: According to analysts, CME Group's stock has a predicted upside of 9.86% based on their 12-month price targets.
What analysts cover CME Group?: CME Group has been rated by Atlantic Securities, Credit Suisse Group, Deutsche Bank Aktiengesellschaft, Morgan Stanley, Raymond James, Rosenblatt Securities, and UBS Group in the past 90 days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

This page (NASDAQ:CME) was last updated on 9/8/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial Subscription Here